2,093
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroids

, , , ORCID Icon, &
Pages 234-238 | Received 16 Sep 2020, Accepted 17 Dec 2020, Published online: 26 Jan 2021

References

  • Hindryckx P, Jairath V, D'Haens G. Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 2016;13(11):654–664.
  • Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4(4):431–437.
  • Fornaro R, Caratto M, Barbruni G, et al. Surgical and medical treatment in patients with acute severe ulcerative colitis. J Dig Dis. 2015;16(10):558–567.
  • Harbord M, Eliakim R, Bettenworth D, European Crohn’s and Colitis Organisation [ECCO], et al. Third european evidence-based consensus on diagnosis and management of ulcerative colitis. part 2: Current management. J Crohns Colitis. 2017;11(7):769–784.
  • Dignass A, Eliakim R, Magro F, et al. Second european evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: Definitions and diagnosis. J Crohns Colitis. 2012;6(10):965–990.
  • Faubion WA, Jr, Loftus EV, Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121(2):255–260.
  • Duijvis NW, Ten Hove AS, Ponsioen CI, et al. Similar short- and long-term colectomy rates with ciclosporin and infliximab treatment in hospitalised ulcerative colitis patients. ECCOJC. 2016;10(7):821–827.
  • Narula N, Marshall JK, Colombel JF, et al. Systematic review and meta-analysis: Infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids. Am J Gastroenterol. 2016;111(4):477–491.
  • Yoon JY, Cheon JH, Park JJ, et al. Clinical outcomes and factors for response prediction after the first course of corticosteroid therapy in patients with active ulcerative colitis. J Gastroenterol Hepatol. 2011;26(7):1114–1122.
  • Meyers S, Lerer PK, Feuer EJ, et al. Predicting the outcome of corticoid therapy for acute ulcerative colitis. results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol. 1987;9(1):50–54.
  • Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5(1):103–110.
  • Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol. 2005;17(1):79–84.
  • Moskovitz DN, Van Assche G, Maenhout B, et al. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4(6):760–765.
  • Gustavsson A, Halfvarson J, Magnuson A, et al. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol. 2007;102(11):2513–2519.
  • Krauthammer A, Tzivinikos C, Assa A, et al. Long-term outcomes of paediatric patients admitted with acute severe colitis- A multicentre study from the paediatric IBD porto group of ESPGHAN. J Crohns Colitis. 2019;13(12):1518–1526.
  • Salameh R, Kirchgesner J, Allez M, et al. Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids. Aliment Pharmacol Ther. 2020;51(11):1096–1104.
  • Garcia-Planella E, Mañosa M, Van Domselaar M, et al. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Dig Liver Dis. 2012;44(3):206–210.
  • Targownik LE, Nugent Z, Singh H, et al. Prevalence of and outcomes associated with corticosteroid prescription in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(4):622–630.
  • Llao J, Naves JE, Ruiz-Cerulla A, et al. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies. Dig Liver Dis. 2016;48(6):608–612.
  • Jeon HH, Lee HJ, Jang HW, et al. Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis. WJG. 2013;19(2):265–273.
  • Sidoroff M, Kolho KL. Glucocorticoid sensitivity in inflammatory bowel disease. Ann Med. 2012;44(6):578–587.